Pierce Phosphatase Inhibitor Mini Tablets, 20 Tablets and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0454543
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $390.53
About this award
The University of Virginia awarded contract A207_PO-0454543 to Life Technologies Corporation on July 3, 2026, for the procurement of laboratory reagents and biochemical products. The contract encompasses two distinct line items: Pierce Phosphatase Inhibitor Mini Tablets (20 tablets) valued at $220.88 per unit and Pierce Protease Inhibitor Mini Tablets (Ethylenediaminetetraacetic acid-free formulation) valued at $169.65 per unit. Both items were procured in a quantity of one unit each and are designated for delivery to Ben Genenger.
The total contract value is $390.53. This award represents a routine procurement of specialized laboratory inhibitor products, consistent with the research and scientific operations conducted by the University of Virginia. The line items indicate consumable supplies for laboratory use, typical of institutional research support contracts managed by academic institutions in Virginia.
Line items
| Item | Total |
|---|---|
| Pierce Phosphatase Inhibitor Mini Tablets, 20 Tablets | $220.88 |
| Pierce Protease Inhibitor Mini Tablets, EDTA-free | $169.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0454543?
Contract A207_PO-0454543 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on July 3, 2026.
How much is contract A207_PO-0454543 worth?
Its cumulative value is $390.53.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award